Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
44 hedge funds and large institutions have $24M invested in Thorne Healthtech, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 6 closing their positions.
122% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 9
9% more capital invested
Capital invested by funds: $22.1M → $24M (+$1.93M)
0.56% more ownership
Funds ownership: 8.94% → 9.49% (+0.56%)
0% more funds holding
Funds holding: 44 → 44 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$1.3M |
| 2 |
BlackRock
New York
|
+$376K |
| 3 |
RA
Royce & Associates
New York
|
+$255K |
| 4 |
State Street
Boston,
Massachusetts
|
+$190K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$167K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
MYDA Advisors
Woodmere,
New York
|
-$615K |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$352K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$89.9K |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$79.6K |
| 5 |
VF
Virtu Financial
New York
|
-$62K |
THRN Hedge Fund Activity: Q2 2023 in Review
44 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q2 2023, worth a combined $24M — up 8.8% from $22.1M a quarter earlier.
Fund positioning in THRN was balanced in Q2 2023: 6 funds opened new positions, 6 closed out, 20 added to existing stakes and 9 trimmed.
The largest buyer was Cresset Asset Management, opening a new position worth an estimated $1.3M. The largest seller was MYDA Advisors, exiting entirely with an estimated $615K sold.
- 44 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $24M of Thorne Healthtech, Inc. Common Stock stock for Q2 2023, up 8.8% quarter-over-quarter.
- 6 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q2 2023 and 6 closed out, a net change of 0 holders.
- The largest Thorne Healthtech, Inc. Common Stock buyer in Q2 2023 was Cresset Asset Management, an estimated $1.3M added.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q2 2023 was MYDA Advisors, an estimated $615K sold.
Based on aggregated 13F filings for Q2 2023.